LAWRENCE, Mass., Aug. 1, 2014 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative
dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and
Mathew Towse, Chief Financial
Officer, will present at the 34th Annual Canaccord
Genuity Growth Conference being held at the InterContinental in
Boston, MA, on Wednesday, August 13th at 4:30 p.m. ET. A webcast of the event will
be made available at http://ir.nxstage.com/.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of end-stage renal disease,
or ESRD, and acute kidney failure. For more information on NxStage
and its products, please visit the company's website at
http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Examples of these forward-looking statements include
statements as to Messrs. Burbank and Towse's plans to present at
this conference. NxStage specifically disclaims any
obligation to update these forward-looking statements. These
forward-looking statements should not be relied upon as
representing NxStage's expectations or beliefs as of any date
subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
SOURCE NxStage Medical Inc.